← Evidence map

TrialBreast cancer research and treatment2022

Implication of body mass index (BMI) on the biological and clinical effects of endocrine therapy plus abemaciclib as neoadjuvant therapy for early breast cancer patients.

Maria Alice Franzoi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2022
2023
2024
2025
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35076812